Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Antabuse
Active Ingredient: Disulfiram 200mg
Dosage Form: Effervescent tablet
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Recipharm Pharmaservices Pvt. Limited., Nelamangala, India
   
Product: Ezetimibe Sandoz
Active Ingredient: Ezetimibe 10mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Lek Pharmaceuticals d.d., Ljubljana, Slovenia
   
Product: Metaraminol
Active Ingredient: Metaraminol tartrate 0.95mg/mL equivalent to metaraminol 0.5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Max Health Limited
Manufacturer: Torbay and South Devon NHS Foundation Trust, Paignton, United Kingdom
   
Product: Metaraminol
Active Ingredient: Metaraminol tartrate 19mg/mL equivalent to metaraminol 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Max Health Limited
Manufacturer: Torbay and South Devon NHS Foundation Trust, Paignton, United Kingdom


Dated this 13th day of January 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).